Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...

For most people, a cataract diagnosis once meant accepting blurry, faded vision as an inevitable part of aging. But at Frantz EyeCare, that story is being rewritten, one patient at a time, thanks to a ...

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...

When text on street signs starts to blur or night driving feels harder than it used to, choosing a certified ophthalmologist in Cape Coral becomes less of ...

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together, a branded content series ...

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...

One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.

Retained lens fragments are a frustrating complication that can challenge even the most meticulous cataract surgeon.While modern phacoemulsification has made the procedure remarkably efficient, the ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific abstracts highlighting its commercial products VEVYE® ...

I testified on three Bills at the Colorado Assembly on March 9, 2026. For the third time in a decade, Legislative Democrats blocked a bill requiring safety regulations and inspections for second ...